The GRM7 gene, early response to risperidone and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The GRM7 gene, early response to risperidone and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume 17, Issue 2, Pages 146-154
Publisher
Springer Nature
Online
2016-02-09
DOI
10.1038/tpj.2015.90
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How antipsychotics impact the different dimensions of Schizophrenia: A test of competing hypotheses
- (2014) Tiago Reis Marques et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Determinants of Antipsychotic Response in Schizophrenia
- (2014) Jonathan Rabinowitz et al. JOURNAL OF CLINICAL PSYCHIATRY
- Early improvement as a predictor of treatment response and remission in patients with schizophrenia: A pooled, post-hoc analysis from the asenapine development program
- (2014) Stefan Leucht et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Clinically meaningful biomarkers for psychosis: A systematic and quantitative review
- (2014) Diana Prata et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study
- (2013) Henry A. Nasrallah et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Pharmacogenetics of clinical response to risperidone
- (2013) Adrián LLerena et al. PHARMACOGENOMICS
- Association Between Symptom Dimensions and Categorical Diagnoses of Psychosis: A Cross-sectional and Longitudinal Investigation
- (2013) Manuela Russo et al. SCHIZOPHRENIA BULLETIN
- Pharmacogenomics can improve antipsychotic treatment in schizophrenia
- (2013) Qingqing Xu et al. Frontiers of Medicine
- Delayed- and early-onset hypotheses of antipsychotic drug action in the negative symptoms of schizophrenia
- (2012) Stephen Z. Levine et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Annotation of functional variation in personal genomes using RegulomeDB
- (2012) A. P. Boyle et al. GENOME RESEARCH
- Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function
- (2012) J C Stingl et al. MOLECULAR PSYCHIATRY
- Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
- (2012) Masaaki Ogasa et al. PSYCHOPHARMACOLOGY
- Early symptom response to antipsychotic medication as a marker of subsequent symptom change: An eighteen-month follow-up study of recent episode schizophrenia
- (2012) Stephen Z. Levine et al. SCHIZOPHRENIA RESEARCH
- Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia
- (2011) Stephen J Ruberg et al. BMC Psychiatry
- Are all antipsychotic drugs the same?
- (2011) Stefan Leucht et al. BRITISH JOURNAL OF PSYCHIATRY
- Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia
- (2011) Maria J. Arranz et al. CNS DRUGS
- Early improvement on antipsychotic treatment as a predictor of subsequent response in schizophrenia: analyses from ziprasidone clinical studies
- (2011) Cedric O'Gorman et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder
- (2011) Rebecca Schennach-Wolff et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
- (2011) Thomas RE Barnes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia
- (2011) Joanna M. Wierońska et al. PSYCHOPHARMACOLOGY
- Trajectories of response to treatment with atypical antipsychotic medication in patients with schizophrenia pooled from 6 double-blind, randomized clinical trials
- (2011) Virginia Stauffer et al. SCHIZOPHRENIA RESEARCH
- Elaboration on the Early-Onset Hypothesis of Antipsychotic Drug Action: Treatment Response Trajectories
- (2010) Stephen Z. Levine et al. BIOLOGICAL PSYCHIATRY
- Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction
- (2010) Jian-Ping Zhang et al. Expert Opinion on Drug Metabolism & Toxicology
- Early Onset of Antipsychotic Action in Schizophrenia
- (2010) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: A decade of advance
- (2010) Suat Ying Tan Cherlyn et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- New Copy Number Variations in Schizophrenia
- (2010) Chiara Magri et al. PLoS One
- MDR1 gene polymorphisms and response to acute risperidone treatment
- (2010) Matej Kastelic et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis
- (2010) Virginia L. Stauffer et al. PSYCHIATRY RESEARCH
- The heterogeneity of antipsychotic response in the treatment of schizophrenia
- (2010) M. Case et al. PSYCHOLOGICAL MEDICINE
- The different trajectories of antipsychotic response: antipsychotics versus placebo
- (2010) T. R. Marques et al. PSYCHOLOGICAL MEDICINE
- The PANSS Should Be Rescaled
- (2010) S. Leucht et al. SCHIZOPHRENIA BULLETIN
- How to read and understand and use systematic reviews and meta-analyses
- (2009) S. Leucht et al. ACTA PSYCHIATRICA SCANDINAVICA
- Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis
- (2009) Anna C Need et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- A family-based association study of DNA sequence variants in GRM7 with schizophrenia in an Indonesian population
- (2009) Clarissa Ganda et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics
- (2009) J L McClay et al. MOLECULAR PSYCHIATRY
- Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia
- (2009) Bruce J Kinon et al. NEUROPSYCHOPHARMACOLOGY
- Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia
- (2009) Hiroki Shibata et al. PSYCHIATRY RESEARCH
- Should the PANSS Be Rescaled?
- (2009) M. Obermeier et al. SCHIZOPHRENIA BULLETIN
- A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
- (2008) Stefan Leucht et al. AMERICAN JOURNAL OF PSYCHIATRY
- How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
- (2008) S Leucht et al. MOLECULAR PSYCHIATRY
- Genomewide association for schizophrenia in the CATIE study: results of stage 1
- (2008) P F Sullivan et al. MOLECULAR PSYCHIATRY
- Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents
- (2008) A. Pałucha-Poniewiera et al. NEUROPHARMACOLOGY
- Evidence for Selective microRNAs and Their Effectors as Common Long-Term Targets for the Actions of Mood Stabilizers
- (2008) Rulun Zhou et al. NEUROPSYCHOPHARMACOLOGY
- Presynaptic metabotropic glutamate receptors regulate glutamatergic input to dopamine neurons in the ventral tegmental area
- (2008) M. de Rover et al. NEUROSCIENCE
- Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia☆
- (2008) B KINON et al. SCHIZOPHRENIA RESEARCH
- A polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophrenia
- (2008) Tsuyuka Ohtsuki et al. SCHIZOPHRENIA RESEARCH
- Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia
- (2007) H. Ascher-Svanum et al. SCHIZOPHRENIA BULLETIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More